CN102763755A - Peanut brittle for preventing and controlling intestinal tract disease - Google Patents
Peanut brittle for preventing and controlling intestinal tract disease Download PDFInfo
- Publication number
- CN102763755A CN102763755A CN2011101191642A CN201110119164A CN102763755A CN 102763755 A CN102763755 A CN 102763755A CN 2011101191642 A CN2011101191642 A CN 2011101191642A CN 201110119164 A CN201110119164 A CN 201110119164A CN 102763755 A CN102763755 A CN 102763755A
- Authority
- CN
- China
- Prior art keywords
- peanut
- product
- harmful bacteria
- tract disease
- intestinal tract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A peanut brittle for preventing and controlling intestinal tract disease is a food therapy product which is specially used to treat intestinal tract disease in the present invention. The product is prepared from peanut, sweet rice flour, white sugar, barley malt and probiotics. The probiotic therapy can be adopted to remove and kill harmful intestinal bacteria, change pH value of the gastrointestinal tract and promote the body to generate a particular type of antibody, thus correcting body's excessive immune response generated to harmful bacteria, eliminating inflammation and providing a healthy gastrointestinal tract.
Description
A kind of enterogastritis control peanut brittle is a kind of dietary product of specially controlling enterogastritis of inventing at present.This product is to be formed by peanut, glutinous rice flour, white granulated sugar, fructus hordei germinatus, probiotic formulations.Before the present invention, a peanut sugar is arranged on market, its flavor is sweet crisp fragrant, and the present invention is different with the former, and the present invention also is furnished with probio except that characteristic with the former and local flavor.This number of live bacteria of probiotics is up to 3,000 hundred million/gram; After these bacteriums get into human bodies, can growth and breeding, kill various harmful microorganisms and germ in the enteron aisle; And can produce a variety of organized enzymes, like amylase, protease, lipase, lactase, peptase, cellulase etc.These organized enzymes can effectively suppress the formation of cancer cell.U.S. scientist mark A cloth Shandong Neck doctor had once write a book, and title is " probio is best medicine ", and disease is derived from the unbalance of flora.As long as there be the quantity increase of a kind of pathogenetic bacteria in intestines will cause intestinal irritable syndrome.The harmful bacteria in the intestines not only can driven and kill to probiotic therapy away; Can also change GI pH value, impel health to produce certain antibody, thereby correct the excessive immune response that health produces harmful bacteria; And diminish inflammation, go back the intestines and stomach of your health.
The object of the invention is invented a peanut sugar food exactly and is prevented and treated the generation of enterogastritis.
Formula material, prescription ratio, preparation method, formulation principle
Peanut 35%, glutinous rice 50%, fructus hordei germinatus malt sugar 10%, white granulated sugar 2%, probio 50 grams
The preparation method: fry peanut and glutinous rice and pulverize, after put white granulated sugar, probio with the malt sugar mix, become square with the mallet mallet again, pack qualified products.
Formulation principle: sesame---be natural cholesterol therapeutant.Sesame has the effect that suppresses the generation of LDL cholesterol, and this will give the credit to a kind of polyphenoils that is called sesamol.The antioxidation of sesamol is embodied in and prevents that LDL is oxidized.As long as LDL is not oxidized, the gathering of the macrophage of the foreign matter of eating also just has been suppressed, and the remains of macrophage so just can not occur, and it is narrow that vascular wall can not become.So, can avoid arteriosclerotic generation effectively through sesamol.Scientist's research shows that the oxidation resistance of sesamol is 10 times of hyperlipidemia curative probacol.In addition, contain sesame alcohol glycocide composition in the sesame seed and be ingested behind the human body, intestinal bacterium can be changed it into sesame alcohol, also shows very strong oxidation resistance.It is thus clear that sesame is a cholesterol therapeutant natural, strong effect.
Glutinous rice---be a kind of carbohydrate, it contains starch, glucose and crude protein.It can increase body energy, and each organ can normally be moved.
White granulated sugar---it is sweet to distinguish the flavor of, and can improve mouthfeel.
Fructus hordei germinatus malt sugar---fructus hordei germinatus can help digest, and whets the appetite.Malt sugar can carry out bonding, and sugar is shaped.
Claims (3)
1. an enterogastritis is prevented and treated peanut brittle, it is characterized in that:
(1) this product is to be formed by peanut, glutinous rice flour, white granulated sugar, fructus hordei germinatus, probiotic formulations.
(2) this product includes probio, not only can drive and kill the harmful bacteria in the intestines away, can also change GI pH value, impels health to produce certain antibody, thereby corrects the excessive immune response that health produces harmful bacteria, and diminish inflammation.
2. according to claim (1), this product is to be formed by peanut, glutinous rice flour, white granulated sugar, fructus hordei germinatus, probiotic formulations.
3. according to claim (2), this product includes probio, not only can drive and kill the harmful bacteria in the intestines away; Can also change GI pH value; Impel health to produce certain antibody, thereby correct the excessive immune response that health produces harmful bacteria, and diminish inflammation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101191642A CN102763755A (en) | 2011-05-01 | 2011-05-01 | Peanut brittle for preventing and controlling intestinal tract disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101191642A CN102763755A (en) | 2011-05-01 | 2011-05-01 | Peanut brittle for preventing and controlling intestinal tract disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102763755A true CN102763755A (en) | 2012-11-07 |
Family
ID=47091519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101191642A Pending CN102763755A (en) | 2011-05-01 | 2011-05-01 | Peanut brittle for preventing and controlling intestinal tract disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102763755A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103749925A (en) * | 2014-01-07 | 2014-04-30 | 秦世昌 | Fructose |
-
2011
- 2011-05-01 CN CN2011101191642A patent/CN102763755A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103749925A (en) * | 2014-01-07 | 2014-04-30 | 秦世昌 | Fructose |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ignat et al. | Current functionality and potential improvements of non-alcoholic fermented cereal beverages | |
| Lazo‐Vélez et al. | Application of Saccharomyces cerevisiae var. boulardii in food processing: a review | |
| Bird et al. | Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics | |
| Behera et al. | Health benefits of fermented bamboo shoots: The twenty-first century green gold of northeast India | |
| Rasika et al. | Probiotic delivery through non-dairy plant-based food matrices | |
| JP2008504038A (en) | Pre-biological preparation | |
| CN103431467B (en) | Asparagus extract bifidobacterium fermentation activity beverage and preparation method thereof | |
| JP2006296245A (en) | Fermented ginger juice, method for producing the same, and food and drink | |
| Szlufman et al. | Role of probiotic bacilli in developing synbiotic food: Challenges and opportunities | |
| Mashau et al. | Non-alcoholic fermentation of maize (Zea mays) in Sub-Saharan Africa | |
| Sharma et al. | Barley-based probiotic food mixture: health effects and future prospects | |
| Shinde et al. | Maltooligosaccharide forming amylases and their applications in food and pharma industry | |
| Sánchez-Zapata et al. | In vitro evaluation of “horchata” co-products as carbon source for probiotic bacteria growth | |
| Sharma et al. | Barley-based probiotic food mixture: Health effects and future prospects | |
| Rawat et al. | A comprehensive review on nutraceutical potential of underutilized cereals and cereal-based products | |
| CN101407754A (en) | Production process of black fungus rough rice vinegar | |
| KR102021774B1 (en) | Composition for bowel movement promotion or diet and manufacturing method thereof | |
| Horlacher et al. | Learning from tradition: health-promoting potential of traditional lactic acid fermentation to drive innovation in fermented plant-based dairy alternatives | |
| JP6742981B2 (en) | Immunomodulator and its use | |
| CN102763755A (en) | Peanut brittle for preventing and controlling intestinal tract disease | |
| KR101421284B1 (en) | Composition for Improving Constipation and Manufacturing Method thereof | |
| Paul et al. | Fungal biofactories as potential inulinase sources for production of fructooligosaccharides | |
| Giacco et al. | Functional Foods: Can Food Technology Help in the Prevention and Treatment of Diabetes? | |
| da Silva Vale et al. | Exploring Microbial Diversity of Non-Dairy Fermented Beverages with a Focus on Functional Probiotic Microorganisms | |
| Noomhorm et al. | Functional foods, nutraceuticals and probiotics as functional food components |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121107 |